Purchase Order 75N91025P00415
Award Date
6/25/25
Potential Completion Date
12/9/25
Potential Value
$24K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a firm fixed-price purchase order awarded by the National Cancer Institute, a civilian agency, to the National Cancer Center, National Research and Development Agency in Japan. The contract is for $24,000.00 and covers laboratory testing services for the National Cancer Center. The performance period runs from the award date of May 16, 2025 through the ultimate completion date of September 15, 2025. This contract does not have a set-aside designation.</p>
The U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) has awarded a $50,000.00 firm fixed-price purchase order to the Regents of the University of California, San Francisco (UCSF) to obtain historical samples of frozen tumor tissue and adjacent normal lung tissue from never-smoking lung cancer patients, along with accompanying medical documentation and data. This purchase order is part of the NCI's Sherlock-Lung study, an international whole-genome sequencing study of...
This is a $146,105.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to the Radiation Effects Research Foundation, a non-profit organization, to provide updated cancer incidence data in the atomic bomb survivors in Japan. The contract has no set-aside designation and was awarded on August 1, 2019, with a completion date of July 31, 2021. The data being delivered under this contract supports the NIH's research programs related to the...
This $17,053.58 firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency, to an undisclosed prime contractor on September 11, 2024. The contract is for a service agreement with a period of performance through March 10, 2025. No set-aside designation is indicated. The contract award does not provide details about the specific products or services to be delivered, but as the NCI is the funding agency, the work is likely related to the institute's cancer...
<p>This is a firm-fixed-price purchase order for laboratory analysis services awarded by the National Cancer Institute, a civilian federal agency, to an unspecified prime contractor. The contract has a ceiling value of $11,075.00 and a period of performance ending on June 30, 2024. No set-aside designation is indicated. The place of performance is Rockville, Maryland.</p>
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $23,520 purchase order to Human Metabolome Technologies America, Inc. for laboratory testing services. The firm fixed price contract has a period of performance from August 22, 2023 through November 21, 2023 for work to be conducted in Boston, Massachusetts. No subcontractors or set aside designations were identified. The award provides laboratory testing support for the National...
This is a Delivery Order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Melanoma Institute Australia, a foreign-owned non-profit organization. The contract is for $192,500.00 and is related to the NCI Cancer Genome Atlas Program, which involves the collection of tissue samples and data from various types of cancer. There is no set-aside designation for this contract. The contract is a Firm Fixed Price type and has an ultimate completion date of September 30, 2014....
The National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,225 firm fixed-price purchase order contract to N-Of-One, Inc., a self-certified small disadvantaged business, for laboratory testing services. This is the fifth prime federal contract awarded to N-Of-One by the National Cancer Institute between 2019 and 2020, with a total potential value across the awards of $89,700. The contract has an ultimate completion date of September...
This is a $80,002 firm-fixed-price purchase order awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to the University of California, San Francisco (UCSF) for the preparation of tissue samples and medical records from never-smoking, Asian-American women with histologically confirmed lung cancer for the SHERLOCK-LUNG study. The study aims to identify exposure-related mutational signatures in lung cancer tumors from never-smoking women worldwide. The...
<p>This firm-fixed-price purchase order was awarded by the National Cancer Institute, a civilian federal agency, to Abiosciences Inc. for $14,000.00 to provide lab testing services. The award has an ultimate completion date of October 25, 2024 and was made on June 26, 2024. No set-aside designation is mentioned. The contract does not appear to be associated with a larger vehicle.</p>